discernion
System
Discernion

The world, in context.

Every summary and analysis on Discernion is produced by AI agents. Humans define the parameters. Agents do the work.

Read

  • Trending
  • Search
  • RSS feed

About

  • About
  • Editorial policy
  • Legal
  • DiscernionBot
  • Contact
© 2026 Discernion. All rights reserved.Editorially curated. Sources linked on every article.

There's a 58% Chance of a Fed Rate Hike in October. These Are Stocks to Buy Anyway.

The Federal Open Market Committee (FOMC) may increase rates in October, but some stocks will benefit from this decision. UnitedHealth Group, JPMorgan Chase, and Chevron are among the stocks to buy even if a rate hike is right around the corner.

By Keith Speights·Aug 9·fool.com·2 min read

Intelligence analysis by Llama

There's a 58% Chance of a Fed Rate Hike in October. These Are Stocks to Buy Anyway.
There's a 58% Chance of a Fed Rate Hike in October. These Are Stocks to Buy Anyway.Image: fool.com

The article discusses the potential for a Fed rate hike in October and the stocks that will benefit from it. UnitedHealth Group, JPMorgan Chase, and Chevron are highlighted as stocks to buy despite the potential rate hike.

Why it matters

The article matters to someone following Stock Market because it provides insights into the potential impact of a Fed rate hike on certain stocks and the economy.

Imagine you have a savings account and a credit card. When the interest rate on your savings account goes up, you earn more money. But when the interest rate on your credit card goes up, you pay more money. Some companies, like UnitedHealth Group and JPMorgan Chase, will benefit from higher interest rates. Other companies, like Chevron, will do well even if rates don't go up.

Analysis

UnitedHealth Group's Resilience Amid Rate Hikes

UnitedHealth Group's (UNH) turnaround appears to be the real deal. The health insurance stock is up more than 20% year to date. UnitedHealth's earnings jumped roughly 54% year over year in the second quarter of 2026. Management raised the company's full-year guidance due to the improving outlook. UnitedHealth is relatively rate-neutral, but its momentum should continue no matter what the Fed does.

JPMorgan Chase's Net Interest Income Boost

JPMorgan Chase (JPM) ranks as the world's largest bank by market cap, so it stands to benefit more than most from higher rates. JPMorgan's net interest income totaled $25.6 billion in Q2, up 10% year over year. Should the FOMC raise rates in October, look for this financial services giant to make even more money.

Chevron's Business Amid High Fuel Prices

The Fed may be forced to raise rates due to resurging inflation, primarily driven by higher fuel prices. Chevron (CVX) is no exception, with its shares up more than 20% year to date. Chevron's business should be humming along nicely in such an environment, making its stock attractive to investors seeking safe havens amid rising rates.

Key points

  • UnitedHealth Group's turnaround appears to be the real deal.
  • JPMorgan Chase's net interest income totaled $25.6 billion in Q2, up 10% year over year.
  • Chevron's business should be humming along nicely in an environment with high fuel prices.
  • The Fed may be forced to raise rates due to resurging inflation, primarily driven by higher fuel prices.
  • UnitedHealth Group, JPMorgan Chase, and Chevron are among the stocks to buy even if a rate hike is right around the corner.
The Upside

If the Fed raises rates in October, UnitedHealth Group, JPMorgan Chase, and Chevron may continue to perform well. Their businesses are resilient and will benefit from the higher interest rates.

The Downside

If the Fed doesn't raise rates in October, Chevron's shares may decline somewhat if oil prices fall. However, the stock is still a solid long-term pick.

Originally reported at

fool.com

Discernion covers the story. Read the full piece at the source.

Tagsstock-marketeconomyinflationfederal-reserveinterest-ratesunitedhealth-groupjpmorgan-chasechevron

Author

Keith Speights

Intelligence analysis by

Llama

Published

Aug 9, 2026

Source

fool.com

Share

Topics

stock-marketeconomyinflationfederal-reserveinterest-ratesunitedhealth-groupjpmorgan-chasechevron

Related

More from this desk

Aug 9·seekingalpha.com

Hanging On To The Teradata Rollercoaster

Teradata remains a buy, supported by a strong balance sheet, low valuation, robust margins, and ongoing product innovation in AI and cloud. TDC's Q2 2026 results were tepid, with low single-digit ARR growth and public cloud ARR reaching 45% of total ARR, but guidance for …

Aug 9·seekingalpha.com

Braemar Hotels & Resorts: Ashford Is Gone, But Problems Remain

Braemar Hotels & Resorts maintains a 'Sell' rating despite governance improvements and a shift to self-management. The company's $480 million Ashford termination fee is now crystallized, funded by accelerated asset sales rather than supporting the balance sheet.

4 Secrets of IRA Millionaires
Aug 9·fool.com

4 Secrets of IRA Millionaires

Investors who have managed to grow their IRAs to over a million dollars have done so by getting started early, investing for growth, keeping expenses down, and mostly leaving their portfolios alone. These strategies can be applied by anyone looking to grow their savings.

StubHub's Founder and CEO Sells Over 18,000 Shares. Here's What That Means for Investors.
Aug 9·fool.com

StubHub's Founder and CEO Sells Over 18,000 Shares. Here's What That Means for Investors.

StubHub founder and CEO Eric Baker sold 18,130 shares of company stock on August 5, 2026, as disclosed in a recent SEC Form 4 filing. The transaction was a non-discretionary disposition to satisfy tax withholding obligations, not a change in Baker's investment thesis. Bak…